The Limited Times

Now you can see non-English news...

Against the background of the publication of efficacy data against the virus: The FDA is discussing the approval of the administration of the third vaccine dose - Walla! news

2021-09-17T13:57:43.075Z


The US Food and Drug Administration is discussing Pfizer's request to approve the "booster" dose, with the participation of Dr. Elrai Price, who will present data from Israel. This is against the background of the data published yesterday which show that the third dose of the vaccine against the virus, improves ten times more than the protection against infection and serious illness.


  • news

  • Corona

Against the background of the publication of efficacy data against the virus: The FDA discusses approval of the third dose of vaccine

The US Food and Drug Administration is discussing Pfizer's request to approve the "booster" dose, with the participation of Dr. Elrai Price, who will present data from Israel.

This is against the background of the data published yesterday which show that the third dose of the vaccine against the virus, improves ten times more than the protection against infection and serious illness.

Tags

  • Corona virus

  • FDA

  • Pfizer

  • Vaccines

News agencies

Friday, 17 September 2021, 15:59 Updated: 16:54

  • Share on Facebook

  • Share on WhatsApp

  • Share on general

  • Share on general

  • Share on Twitter

  • Share on Email

0 comments

  • A virtual summit to mark the anniversary of the Abrahamic Agreements

  • Assad arrived in the Kremlin for an unknown visit in advance and was scheduled to ...

  • Linken on the submarine deal with Australia: "Want to ensure ...

  • Bennett: The escape from prison is a wake-up call, the systems ...

  • Bennett in an interview with Walla !: I say no to vaccine opponents ...

  • 2 buildings were evacuated in Bnei Brak for fear of collapsing 17.09.21

  • With masks, tests and great excitement: 2,458,000 ...

  • Clashes in the West Bank following the escape of terrorists, dozens ...

  • Abla Danger answers surfers' questions

  • Tip for the pizza courier - triangle

  • The twins who look like Ariana Grande

  • A flight attendant explains why it is important to switch phones to flight mode

In the video: Prof. Ash announces the cancellation of the green label for private pools and expresses disappointment with the rate of decrease in morbidity (Photo: Knesset Channel)

The US Food and Drug Administration (FDA) today (Friday) discussed the safety of a third dose, "booster", against the corona virus.

This, after Pfizer submitted an application for approval of the additional dose.



During the discussions, the head of the public health services at the Ministry of Health, Dr. Sharon Elrai Price, will present the truth data from Israel. Yesterday it was published in the medical journal The New England Journal of Medicine that the third dose of the virus The study, which refers to the Booster dose of the pharmaceutical company Pfizer, indicates a significant increase in protection compared to those who have been vaccinated with only two doses, and it has been five months or more since he received the second dose.

More on Walla!

Study: A third dose of Pfizer vaccine increases 10-fold protection from corona

To the full article

More on Walla!

  • "Sorry we were not able to convince Chai to get vaccinated against Corona. This death could have been avoided"

  • 50 corona patients where trained with a false negative test;

    Bennett allowed their time for a police investigation

  • The future is already here: the smart test that detects an increased risk of having a stroke

Using data from Israel (Photo: Reuters)

In fact, if the chance of vaccinated people being infected in the Delta is currently about half that of non-vaccinated people, as evidenced by various studies, the booster dose lowers this relative chance to 5%.

That is, a third dose of "Pfizer" vaccine returns the immune protection to a level of about 95% - similar to the original protection of a "fresh" vaccine that was observed against a less contagious alpha strain.

Future studies will be able to determine the long-term efficacy of a third dose of the vaccine against Delta and against future variants.

  • Share on Facebook

  • Share on WhatsApp

  • Share on general

  • Share on general

  • Share on Twitter

  • Share on Email

0 comments

Source: walla

All news articles on 2021-09-17

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.